GlassScriptPhysician profile
Usman A Tohid
NPI 1508292483
$6,652.65
in general payments reported to CMS, 2019-2025
16 companies · $1,141 in 2025
The $1,141 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $842 · 2022: $1,401 · 2023: $1,700 · 2024: $1,568 · 2025: $1,141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,409.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,298.12 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $752.85 | 2021-2025 | Uzedy, Austedo Xr, Austedo |
| Janssen Pharmaceuticals, INC | $706.03 | 2021-2025 | Invega Sustenna, Spravato, Invega Trinza |
| Alkermes, INC. | $621.47 | 2021-2025 | Aristada, Lybalvi, Aristada Initio |
| Otsuka America Pharmaceutical, INC. | $556.17 | 2021-2025 | Abilify Maintena, Rexulti, Abilify Asimtufii |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $546.65 | 2022-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $430.87 | 2021-2025 | Ingrezza |
| E.R. Squibb & Sons, L.L.C. | $301.95 | 2024-2025 | Cobenfy |
| Axsome Therapeutics, INC. | $166.78 | 2023-2025 | Auvelity |
| Indivior INC. | $85.97 | 2021-2023 | Perseris |
| Vanda Pharmaceuticals INC. | $68.19 | 2021-2024 | Fanapt, Hetlioz |
| Ironshore Pharmaceuticals INC. | $40.21 | 2022-2024 | Jornay Pm |
| Sunovion Pharmaceuticals INC. | $25.52 | 2021 | |
| Lundbeck LLC | $18.86 | 2025 | Rexulti |
| Corium, LLC | $16.88 | 2024 | Azstarys |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $16.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usman Tohid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.